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Abstract
Following the submission of application EFSA-GMO-RX-010 under Regulation (EC) No 1829/2003 from
Bayer, the Panel on Genetically Modiﬁed Organisms of the European Food Safety Authority (GMO
Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted in the context of the
renewal of authorisation application for the herbicide-tolerant genetically modiﬁed LLCotton25, for food
and feed uses, import and processing, excluding cultivation within the EU. The data received in the
context of this renewal application contained post-market environmental monitoring reports, a
systematic search and evaluation of literature, updated bioinformatic analyses and additional
documents or studies performed by or on behalf of the applicant. In addition, the applicant provided
sequence data on the LLCotton25 event using the material from a commercial variety that, according
to the applicant, may be imported into the EU at the time of this renewal application. The GMO
Panel assessed these data for possible new hazards, modiﬁed exposure or new scientiﬁc uncertainties
identiﬁed during the authorisation period and not previously assessed in the context of the original
application. The GMO Panel concludes that there is no evidence in the renewal application EFSA-GMO-
RX-010 for new hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the
conclusions of the original risk assessment on LLCotton25.
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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Summary
Following the submission of application EFSA-GMO-RX-010 under Regulation (EC) No 1829/2003
from Bayer CropScience N.V., the Panel on Genetically Modiﬁed Organisms of the European Food
Safety Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted
in the context of the renewal of authorisation application for the herbicide-tolerant genetically modiﬁed
LLCotton25. The scope of renewal application EFSA-GMO-RX-010 is for placing on the market of
products containing, consisting of, or produced from LLCotton25, excluding cultivation within the
European Union (EU).
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-010,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications. The data received in the context of the renewal application EFSA-
GMO-RX-010 contained: post-market environmental monitoring reports, an evaluation of the literature
retrieved by a systematic search, updated bioinformatics analyses, and additional studies performed by
or on behalf of the applicant. The applicant also provided sequence data on the LLCotton25 event
using the material from a commercial variety that, according to the applicant, may be imported into
the EU at the time of this renewal application. The GMO Panel assessed these data for possible new
hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period
and not previously assessed in the context of the original application.
The GMO Panel concludes that there is no evidence in renewal application EFSA-GMO-RX-010 for
new hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the conclusions of the
original risk assessment on LLCotton25 (EFSA, 2006).
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1. Introduction
1.1. Background
On 30 November 2017, the European Food Safety Authority (EFSA) received from the European
Commission (DG SANTE) application EFSA-GMO-RX-010 by Bayer for the renewal of authorisation of
genetically modiﬁed (GM) LLCotton25 (Unique Identiﬁer ACS-GHØØ1-3) for the placing on the market
of products containing, consisting of, or produced from this GM cotton submitted within the framework
of Regulation (EC) No 1829/2003.1 Before sending the application to EFSA, the European Commission
conﬁrmed whether the data submitted in the context of this renewal application were in line with the
legal requirements laid down in Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving application EFSA-GMO-RX-010, and in accordance with Articles 5(2)(b) and 17(2)(b)
of Regulation (EC) No 1829/2003, EFSA informed Member States and made the summary of the
application available to the public on the EFSA website.2
On 15 March 2018, EFSA declared the application valid in accordance with Articles 6(1) and 18(1)
of Regulation (EC) No 1829/2003. EFSA made the valid application available to Member States and the
European Commission, and consulted nominated risk assessment bodies of Member States, including
national Competent Authorities within the meaning of Directive 2001/18/EC following the requirements
of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member
States had three months after the opening of the Member State commenting period (until 18 June
2018) to make their opinion known.
Following the submission of application EFSA-GMO-NL-2005-13 and the publication of the EFSA
scientiﬁc opinion (EFSA, 2006), the placing on the market of LLCotton25 for products containing,
consisting of, or produced from this GM cotton, excluding cultivation in the European Union (EU), was
authorised by Commission Decision 2008/837/EC.3 A copy of this authorisation was provided by the
applicant.4
EFSA requested additional information on 10 April 2018 and 29 August 2018. The applicant
submitted its reply on 8 June 2018 and 24 September 2018, respectively.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of six months was extended
accordingly, in line with Articles 6(1), 6(2), 18(1) and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
context of the renewal of authorisation application for the placing on the market of products
containing, consisting of, or produced from GM LLCotton25, in accordance with Articles 11 and 23 of
Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of genetically modiﬁed
organisms (GMOs) or food and feed containing or consisting of GMOs, conditions for the protection of
particular ecosystems/environment and/or geographical areas should be indicated in accordance with
Articles 6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
2 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2017-00814
3 COMMISSION DECISION of 29 October 2008 authorising the placing on the market of products containing, consisting of, or
produced from genetically modiﬁed LLCotton25 (ACS-GHØØ1-3) pursuant to Regulation (EC) No 1829/2003 of the European
Parliament and of the Council. Ofﬁcial Journal of the European Union L 299/36, 8.11.2008.
4 Dossier: LLCotton25 renewal – Annex 1.
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the food and feed and/or food and feed produced from it), which are matters related to risk
management.
2. Data and methodologies
2.1. Data
The data for application EFSA-GMO-RX-010 provided by the applicant at the time of submission, or
in reply to requests for additional information, are speciﬁed below.
The applicant submitted sequence data on LLCotton25 event5 and clariﬁed that the material used to
newly determine the LLCotton25 event sequence is representative of LLCotton25 varieties currently on
the market, which may be imported into the EU.6 The applicant also clariﬁed that this newly determined
LLCotton25 event sequence is identical to the previously assessed LLCotton25 event sequence (submitted
in application EFSA-GMO-NL-2010-77,7 EFSA GMO Panel, 2014) corrected for sequencing errors with
respect to the originally provided sequence (application EFSA-GMO-NL-2005-13, EFSA, 2006).5,8
2.1.1. Post-market monitoring reports9
Based on the outcome of the initial food and feed risk assessment, a post-market monitoring plan
for monitoring of GM food and feed was not required by the authorisation decision. The
implementation of a post-market environmental monitoring (PMEM) plan, consisting of a general
surveillance plan to check for any adverse effects on the environment arising from LLCotton25, was a
condition for the authorisation. As no potential adverse environmental effects were identiﬁed in the
environmental risk assessment of LLCotton25 (EFSA, 2006), case-speciﬁc monitoring was not
considered necessary by the GMO Panel.
The applicant provided eight annual PMEM reports covering a reporting period from October 2008 to
June 2016. The annual PMEM plans submitted by the applicant included (1) the description of a
centralised system established by EuropaBio for the collection of information recorded by various
operators (federations involved in cotton seeds import and processing) on any observed adverse effect(s)
on human health and the environment arising from handling of cotton possibly containing LLCotton25;
(2) the reports of the surveillance activities conducted by such operators; and (3) the review of relevant
scientiﬁc peer-reviewed studies retrieved from literature searches.
2.1.2. Systematic search and evaluation of literature10
In addition to the eight separate literature searches provided as part of the annual PMEM reports,
the applicant performed a systematic literature search covering the period from January 2007 till
September 2014, in accordance with the recommendations on literature searching outlined in EFSA
(2010, 2017a). However, search terms and electronic bibliographic databases were not consistent
throughout the searches, as required in the renewal guidance (EFSA GMO Panel, 2015). As requested
on 10 April 2018 by the GMO Panel, a new systematic literature search was performed for LLCotton25
and the newly expressed PAT/bar covering a reporting period from 1 January 2007 until 30 April 2018.
Searches against electronic bibliographic databases, screening of reference lists and internet
searches to specialist databases were performed to identify relevant publications. Altogether, 1,704
publications were retrieved. After applying the eligibility/inclusion criteria deﬁned a priori by the
applicant, seven publications were identiﬁed as relevant for food and feed safety assessment,
molecular characterisation and environmental safety assessment. The list of relevant publications is
provided in Appendix A.
2.1.3. Updated bioinformatic data11
At the time of submission of the renewal dossier, the applicant provided a complete bioinformatic
dataset for LLCotton25 event (using the corrected sequence) including an analysis of the insert and
5 Study number M-585342-01-1 and study number M-600013-01-1.
6 Additional information: 24/09/2018.
7 Study number M-384916-01-1.
8 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2017-00803
9 Dossier: LLCotton25 renewal – Annex 2.
10 Dossier: LLCotton25 renewal – Annex 3; additional information: 8/6/2018.
11 Dossier: LLCotton25 renewal – Section 3b.
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ﬂanking sequences, an analysis of the potential similarity to allergens and toxins of the newly
expressed protein and of all possible open reading frames (ORFs) within the insert and spanning the
junction sites, and an analysis of possible horizontal gene transfer (EFSA, 2017b). The outcome of the
updated bioinformatic analyses is presented in Section 3.3.
2.1.4. Additional documents or studies provided by the applicant12
In line with the renewal guidance requirements (EFSA GMO Panel, 2015), the applicant provided an
overview on the worldwide approvals of LLCotton25 and a list containing the summaries of all studies
performed by or on behalf of the applicant over the course of the authorisation period and not
previously submitted to the EU (Appendix B).
The relevance of the listed studies for molecular characterisation, human and animal safety and the
environment was assessed by the applicant.
On 10 April 2018, the GMO Panel requested the applicant to provide the full study reports of ﬁve of
these studies considered potentially relevant for safety assessment. The applicant submitted the
requested information on 8 June 2018.
2.1.5. Overall assessment as provided by the applicant13
In line with the requirements listed in the renewal guidance (EFSA GMO Panel, 2015), the applicant
provided an overall assessment concluding that information provided in the application for renewal of
authorisation of LLCotton25 for food and feed use and processing in the EU, does not change the
outcome of the original risk assessment (EFSA, 2006).
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation14
The applicant indicated in the dossier that the environmental monitoring plan is appropriate and
does not need any changes.
2.2. Methodologies
The GMO Panel assessed the application for renewal of authorisation of LLCotton25 for food and feed
uses, import and processing in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003.
The GMO Panel took into account the requirements described in its guideline for the risk assessment of
renewal applications of GM food and feed authorised under Regulation (EC) No 1829/2003 (EFSA GMO
Panel, 2015).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion15 and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Evaluation of the post-market monitoring reports
During the general surveillance activities covering the authorisation period of LLCotton25, no
adverse effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
The GMO Panel assessed the applicant’s literature searches on LLCotton25. Although the overall
quality of the performed literature searches is acceptable, the GMO Panel considers that future
searches could be improved. The GMO Panel therefore recommends the applicant for future searches
to:
 ensure that enough search term variation is used (covering possible synonyms, related terms,
acronyms, spelling variants, old and new terminology, brand and generic names, lay and
scientiﬁc terminology, common typos, translation issues);
12 Dossier: LLCotton25 renewal – Section 3c; additional information: 8/6/2018.
13 Dossier: LLCotton25 renewal – Section 4.
14 Dossier: LLCotton25 renewal – Section 5.
15 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2018-00814
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 use truncation consistently; include intended trait-speciﬁc search terms; include controlled vocabulary (subject indexing) in the searches when available, and where
subject headings are available use both free-text terms and controlled vocabulary in the searches.
The GMO Panel acknowledges that no publications raising a safety concern for human and animal
health and the environment which would change the original risk assessment conclusions on
LLCotton25 (EFSA, 2006) have been identiﬁed by the applicant.
3.3. Evaluation of the updated bioinformatic data
The results of the updated bioinformatic analyses of LLCotton25 using the corrected event
sequence conﬁrm that no known endogenous genes were disrupted by the inserts. Analyses of the
amino acid sequence of the newly expressed PAT protein reveal no signiﬁcant similarities to toxins or
allergens. In addition, bioinformatic analyses of the newly created ORFs within the insert or spanning
the junctions with genomic DNA reveal no signiﬁcant similarities to toxins and allergens.
The updated bioinformatic analyses conﬁrm the previous conclusions on the likelihood of
occurrence of horizontal gene transfer for LLCotton25 (e.g. EFSA GMO Panel, 2018). It was concluded
that the unlikely, but theoretically possible, horizontal transfer of recombinant genes from LLCotton25
to bacteria did not raise any environmental safety concern.
3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel evaluated the summary and/or the full study reports of the additional studies
provided (Appendix B). This new information does not raise any concern for human and animal health
and the environment, which would change the original risk assessment conclusions on LLCotton25.
3.5. Evaluation of the overall assessment as provided by the applicant
The GMO Panel evaluated the overall assessment provided by the applicant and conﬁrms that there
is no evidence in renewal application EFSA-GMO-RX-010 indicating new hazards, relevant changes in
exposure or scientiﬁc uncertainties that would change previous conclusions on LLCotton25.
3.6. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The PMEM plan covers general surveillance of imported GM cotton plant material, including
LLCotton25. This general surveillance is coordinated by EuropaBio and implemented by selected
operators (federations involved in cotton seeds import and processing). In addition, the applicant
reviews relevant scientiﬁc publications retrieved from literature searches on an annual basis. The GMO
Panel is of the opinion that the scope of the plan provided by the applicant is consistent with the
scope of LLCotton25 but reminds that monitoring is related to risk management, and thus the ﬁnal
adoption and implementation of the PMEM plan falls outside the mandate of EFSA.
4. Conclusions
Based on the data provided, the GMO Panel concludes that there is no evidence in renewal
application EFSA-GMO-RX-010 for new hazards, modiﬁed exposure or scientiﬁc uncertainties that
would change the conclusions of the original risk assessment on LLCotton25 (EFSA, 2006).
Documentation provided to EFSA
1) Letter from the European Commission to EFSA received on 30 November 2017 for the
continued marketing of genetically modiﬁed cotton LLCotton25 in accordance with articles 11
and 23 of Regulation (EC) No 1829/2003 by Bayer (EFSA-GMO-RX-010).
2) Acknowledgement letter, dated 4 December 2017, from EFSA to the European Commission.
3) Letter from EFSA to applicant dated 22 January 2018 requesting additional information
under completeness check.
4) Letter from applicant to EFSA received on 26 February 2018 providing additional information
under completeness check.
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5) Letter from EFSA to applicant dated 15 March 2018 delivering the ‘Statement of Validity’ for
application EFSA-GMO-RX-010.
6) Letter from EFSA to applicant dated 10 April 2018 requesting additional information and
stopping the clock.
7) Letter from applicant to EFSA received on 8 June 2018 providing additional information.
8) Letter from EFSA to applicant dated 15 June 2018 re-starting the clock from 8 June 2018.
9) Letter from EFSA to applicant dated 29 August 2018 requesting additional information and
stopping the clock.
10) Letter from applicant to EFSA received on 24 September 2018 providing additional
information.
11) Letter from EFSA to applicant dated 24 September 2018 re-starting the clock from
24 September 2018.
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Appendix B – List of additional studies performed by or on behalf of the
applicant over the course of the authorisation period and not previously
submitted to the EU with regard to the evaluation of the safety of the food
and feed for humans, animal or the environment from LLCotton25
Study identiﬁcation Title
M–487218–01–1(a) Avaliac~ao a campo do algod~ao libertylink – Field assessment of LibertyLink cotton
M-384718-01-1(b),(c) LLCotton25: 90-Day toxicity study in the rat by dietary administration of toasted
meal
M-509357-01-1 Structural and functional equivalence of PAT/bar protein produced in Escherichia coli
and LLCotton25, Gossypium hirsutum – Supplement
M-557508-01-1(b) The effect of temperature on PAT/bar as assessed by ELISA
M-554703-01-1(b) The effect of temperature on PAT/bar as assessed by the PAT quantitative activity
assay
M-461494-01-1(b) Recombinant PAT/bar protein: Acute toxicity by oral gavage in female mice
M-475319-01-1(b) PAT/bar protein - Acute toxicity by oral gavage in mice
(a): Report in Portuguese.
(b): Studies for which the full report was requested by the GMO Panel.
(c): The GMO Panel notes that this study did not adhere to EFSA guidance documents relevant for the conduction of 90-day
feeding studies. However, the study was evaluated to exclude any documented adverse effect.
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